DAE HWA Pharmaceutical's chart data is dated 2026-10-08. There is no active technical signal. There are 0 published signal records.
DAE HWA Pharmaceutical last closed at ₩12,000 (-1.07%) on 2026-10-08. Listed on KOSDAQ. Trailing 12 months PER is 48.5×. Its overall grade ranks 141 of 308 stocks in Healthcare.
About this company
DAE HWA Pharmaceutical last closed at ₩12,000 (-1.07%) on 2026-10-08. Listed on KOSDAQ.
Details →Reported results
Position in sector
Healthcare · Overall B · 141/308
Valuation grade C
Dividends
2025 dividend per share · ₩150 · Yield 1.24%
Details →Recent filings
DART · received recent list, not a complete filing history. Factual information, not investment advice.
Related stocks
- 삼성바이오로직스Competitor
국내 바이오의약품 위탁생산(CMO/CDMO) 경쟁사
- 롯데바이오로직스Competitor
바이오의약품 생산·CDMO 분야 경쟁사
- 셀트리온Competitor
바이오시밀러 중심의 국내 바이오의약품 경쟁사
About DAE HWA Pharmaceutical
- What technical signals does DAE HWA Pharmaceutical (067080) have?
- DAE HWA Pharmaceutical current technical signals: no active technical signal.
- Is DAE HWA Pharmaceutical a cup-and-handle pattern?
- No. DAE HWA Pharmaceutical has no valid Cup signal right now.
- What published figures are available for DAE HWA Pharmaceutical?
- Market cap: KRW 223.4B. Trailing 12 months PER: 48.5×. Latest quarter PBR: 2.66×. Dividend yield: 1.24%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about DAE HWA Pharmaceutical, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.